Cathepsin D expression in early cutaneous malignant melanoma

International Journal of Dermatology

Volumn 39, Issue 8, 2000, Pages 599-602

  Bartenjev, Igor ^a   Rudolf, Zvonimir ^a   Štabuc, Borut ^a   Vrhovec, Ivan ^a   Perkovič, Tanja ^a   Kansky, Aleksej ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D;

ADULT; AGED; CANCER GROWTH; CANCER INVASION; CANCER TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EARLY CANCER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PROGNOSIS; PROTEIN EXPRESSION; SKIN METASTASIS; TISSUE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATHEPSIN D; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0033811712     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00025.x     Document Type: Conference Paper

References (32)

1. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
2. Tumor-associated proteases
3. Regulation of lysosomal endopeptidases in malignant neoplasia
4. Cathepsin D as a prognostic indicator for node negative breast cancer patients using both immunoassay and enzymatic assays
5. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast carcinomas
6. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma
7. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck
8. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival
9. Prognostic value of increased lung tumor tissue cathepsin B
10. Cathepsin D in the malignant progression of neoplastic diseases
11. Cathepsin D in breast cancer: A tissue marker associated with metastasis
12. Lysosomal proteases cathepsin D, B, H, L and their inhibitors stefins A and B in head and neck cancer
13. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi
14. Prognostic factors in patients with metastatic malignant melanoma: A multivariant analysis
15. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma
16. Neuron-spezifische Enolaze (NSE)-ein geeigneter Tumormarker des malignen Melanoms?
17. Biochemical and immunohistochemical analysis of cathepsins B, H, L, and D in human melanocytic tumors
18. Revision of the standards for the assessments of hormonal receptors in human breast cancer
19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
20. Radioimunski in encimskoimunski testi
21. Regression models and life tables
22. Does this patient have a mole or a melanoma?
23. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis
24. Thin melanomas with unusual aggressive behavior: A report of nine cases
25. Thickness is not an accurate gauge of prognosis of primary cutaneous melanoma
26. Cathepsin B activity in B16 melanoma cells: A possible marker for metastatic potential
27. Characterization of cathepsin-H-like enzyme from a human melanoma cell line
28. Inhibition of tumor growth, invasion and metastasis in papain-immunized mice
29. Cathepsin D in breast cancer
30. Tumor characteristics involved in the metastatic behavior as an improvement in primary cutaneous melanoma prognostics
31. Prognostic classification of malignant melanomas by combining clinical, histological, and immunohistochemical parameters
32. The expression of proteolytic enzymes at the dermal invading front of primary cutaneous melanoma predicts metastasis